A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
NCT05988073 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 413
Last updated 2026-03-16
Summary
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
Conditions
- Multifocal Motor Neuropathy
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-29
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- United States
- Australia
- Austria
- Belgium
- Bulgaria
- Canada
- China
- Czechia
- Denmark
- France
- Germany
- Italy
- Japan
- Latvia
- Poland
- Romania
- Serbia
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis
NCT02580669 ·Status: TERMINATED ·Phase: NA
-
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
NCT04448938 ·Status: RECRUITING
-
Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome
NCT03357887 ·Status: COMPLETED
-
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
NCT01592552 ·Status: COMPLETED
-
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 ·Status: ENROLLING_BY_INVITATION
-
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158 ·Status: UNKNOWN
-
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
NCT06551649 ·Status: RECRUITING ·Phase: NA
-
Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Clinical Practice
NCT03232463 ·Status: ENROLLING_BY_INVITATION
-
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
NCT04680130 ·Status: ENROLLING_BY_INVITATION
-
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
NCT01620775 ·Status: TERMINATED ·Phase: NA
-
Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
NCT03541226 ·Status: COMPLETED
-
Neuro-ophthalmology and Autoimmune Encephalitis (NODE)
NCT03872284 ·Status: COMPLETED
-
A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).
NCT00978536 ·Status: TERMINATED ·Phase: NA
-
Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis
NCT02058732 ·Status: TERMINATED ·Phase: NA
-
A Cohort of Acute, Ischemic and Rare Neuropathies
NCT05511103 ·Status: UNKNOWN
-
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
NCT03863041 ·Status: COMPLETED ·Phase: NA
-
Molecular and Functional Imaging in Monogenic PD.
NCT05518617 ·Status: RECRUITING
-
Functional MRI Biomarkers of Cognitive Decrements in Diabetes
NCT01705210 ·Status: COMPLETED
-
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
NCT05934188 ·Status: RECRUITING
-
Glymphatic MRI in Clinically Isolated Syndrome
NCT06274671 ·Status: ACTIVE_NOT_RECRUITING
-
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850 ·Status: RECRUITING
-
Natural History of Multiple Sclerosis and Its Mimickers
NCT02504840 ·Status: COMPLETED
-
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
NCT04451265 ·Status: RECRUITING
-
Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
NCT06845644 ·Status: RECRUITING ·Phase: NA
-
Stroke Cerebral Reorganization Pathways (SPECTRE)
NCT06784518 ·Status: NOT_YET_RECRUITING ·Phase: NA